Cargando…
New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown
The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distrib...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372191/ https://www.ncbi.nlm.nih.gov/pubmed/34413924 http://dx.doi.org/10.46697/001c.17692 |
_version_ | 1783739765782216704 |
---|---|
author | Dunlap, Denise Santos, Roberto S. McManus, David D. Buchholz, Bryan O. Hafer, Nathaniel S. Picard, MaryAnn |
author_facet | Dunlap, Denise Santos, Roberto S. McManus, David D. Buchholz, Bryan O. Hafer, Nathaniel S. Picard, MaryAnn |
author_sort | Dunlap, Denise |
collection | PubMed |
description | The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distributed healthcare know-how. Without a cure for COVID-19, the ambiguity concerning how coronavirus-related policies will impact international business remains unclear. Through a multi-method approach, our study sheds light on two key healthcare industry trends: decentralization and deglobalization of clinical trials. We offer actionable strategies to not only mitigate these challenges, but also to take advantage of their new opportunities |
format | Online Article Text |
id | pubmed-8372191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-83721912021-08-18 New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown Dunlap, Denise Santos, Roberto S. McManus, David D. Buchholz, Bryan O. Hafer, Nathaniel S. Picard, MaryAnn AIB Insights Article The 2020s began with a rare coronavirus (COVID-19) disaster, which led to a pandemic-induced recession and Great Lockdown. In response, there has been a worldwide mobilization of resources to detect, treat, and cure the virus. Some policymakers are advocating for the repatriation of globally distributed healthcare know-how. Without a cure for COVID-19, the ambiguity concerning how coronavirus-related policies will impact international business remains unclear. Through a multi-method approach, our study sheds light on two key healthcare industry trends: decentralization and deglobalization of clinical trials. We offer actionable strategies to not only mitigate these challenges, but also to take advantage of their new opportunities 2020-11-03 /pmc/articles/PMC8372191/ /pubmed/34413924 http://dx.doi.org/10.46697/001c.17692 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY-4.0). View this license’s legal deed at http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) and legal code at http://creativecommons.org/licenses/by/4.0/legalcode (https://creativecommons.org/licenses/by/4.0/) for more information. |
spellingShingle | Article Dunlap, Denise Santos, Roberto S. McManus, David D. Buchholz, Bryan O. Hafer, Nathaniel S. Picard, MaryAnn New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown |
title | New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown |
title_full | New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown |
title_fullStr | New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown |
title_full_unstemmed | New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown |
title_short | New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown |
title_sort | new opportunities and cautionary insights about decentralizing and deglobalizing clinical trials during the great lockdown |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372191/ https://www.ncbi.nlm.nih.gov/pubmed/34413924 http://dx.doi.org/10.46697/001c.17692 |
work_keys_str_mv | AT dunlapdenise newopportunitiesandcautionaryinsightsaboutdecentralizinganddeglobalizingclinicaltrialsduringthegreatlockdown AT santosrobertos newopportunitiesandcautionaryinsightsaboutdecentralizinganddeglobalizingclinicaltrialsduringthegreatlockdown AT mcmanusdavidd newopportunitiesandcautionaryinsightsaboutdecentralizinganddeglobalizingclinicaltrialsduringthegreatlockdown AT buchholzbryano newopportunitiesandcautionaryinsightsaboutdecentralizinganddeglobalizingclinicaltrialsduringthegreatlockdown AT hafernathaniels newopportunitiesandcautionaryinsightsaboutdecentralizinganddeglobalizingclinicaltrialsduringthegreatlockdown AT picardmaryann newopportunitiesandcautionaryinsightsaboutdecentralizinganddeglobalizingclinicaltrialsduringthegreatlockdown |